ICON plc
(NASDAQ : ICLR)

( )
ICLR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.00%29.8114.1%$175.41m
HZNPHorizon Therapeutics Plc 0.00%91.625.5%$174.25m
GWPHGW Pharmaceuticals Plc 0.00%218.006.1%$131.46m
CTLTCatalent, Inc. -0.03%109.012.1%$128.21m
ICLRICON plc 0.00%198.034.2%$127.29m
BHCBausch Health Cos., Inc. 0.00%29.810.0%$119.81m
UTHRUnited Therapeutics Corp. 0.00%199.3014.1%$96.38m
JAZZJazz Pharmaceuticals Plc 0.00%163.312.3%$85.88m
SAVACassava Sciences, Inc. 0.00%36.030.0%$71.63m
ARGXargenx SE 0.00%268.980.0%$49.58m
PRGOPerrigo Co. Plc -0.10%40.116.9%$37.24m
SAGESAGE Therapeutics, Inc. 0.00%71.947.6%$35.61m
AMRNAmarin Corp. Plc 3.15%5.241.5%$28.38m
KMPHKemPharm, Inc. 0.00%8.652.0%$27.18m
PCRXPacira Biosciences, Inc. 0.00%68.269.9%$26.36m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.